Frontiers in Pharmacology (Jan 2022)
Corrigendum: Neuroprotective Effects of the Anti-Cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
- Ji-Ning Jia,
- Ji-Ning Jia,
- Ji-Ning Jia,
- Ji-Ning Jia,
- Xi-Xi Yin,
- Qin Li,
- Qin Li,
- Qin Li,
- Qin Li,
- Qi-Wen Guan,
- Qi-Wen Guan,
- Qi-Wen Guan,
- Qi-Wen Guan,
- Nan Yang,
- Nan Yang,
- Nan Yang,
- Nan Yang,
- Kang-Ni Chen,
- Kang-Ni Chen,
- Kang-Ni Chen,
- Kang-Ni Chen,
- Hong-Hao Zhou,
- Hong-Hao Zhou,
- Hong-Hao Zhou,
- Hong-Hao Zhou,
- Xiao-Yuan Mao,
- Xiao-Yuan Mao,
- Xiao-Yuan Mao,
- Xiao-Yuan Mao
Affiliations
- Ji-Ning Jia
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Ji-Ning Jia
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Ji-Ning Jia
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Ji-Ning Jia
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Xi-Xi Yin
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Qin Li
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Qin Li
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Qin Li
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Qin Li
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Qi-Wen Guan
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Qi-Wen Guan
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Qi-Wen Guan
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Qi-Wen Guan
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Nan Yang
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Nan Yang
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Nan Yang
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Nan Yang
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Kang-Ni Chen
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Kang-Ni Chen
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Kang-Ni Chen
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Kang-Ni Chen
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Hong-Hao Zhou
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Hong-Hao Zhou
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Hong-Hao Zhou
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Hong-Hao Zhou
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Xiao-Yuan Mao
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Xiao-Yuan Mao
- Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China
- Xiao-Yuan Mao
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Xiao-Yuan Mao
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- DOI
- https://doi.org/10.3389/fphar.2021.810295
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- lapatinib
- epileptic seizures
- neuroprotection
- ferroptosis
- lipid peroxidation
- glutathione peroxidase 4
